More than 80 drugmakers, stakeholders demand worldwide government action on antibiotic resistance

Every year in the U.S. at least 2 million people become infected with aggressive bacteria that don’t respond to the antibiotics that in years past would have knocked them out without a second thought. With treatment options limited due to mishandling and overprescription of antibiotics, more than 23,000 of those infections are fatal. The CDC and other organizations worldwide have dedicated resources to raising awareness and hospitals have adopted stewardship programs to curb the scourge, but a new “Declaration on Combating Antimicrobial Resistance” has added the voices of more than 80 new organizations to the fight, including drugmakers, biotech companies and other international industry bodies. 

Advertisement
By: Staff

The declaration’s focus spans three broad areas: reducing the development of drug resistance, increasing investment in research and development that meets global public health needs and improving access to high-quality antibiotics for all. Organizations supporting the declaration include:

  • The Infectious Disease Society of America
  • The European Federation of Pharmaceutical Industries and Associations
  • The World Health Organization
  • Johnson & Johnson
  • Merck & Co.
  • Pfizer
  • AstraZeneca
  • GlaxoSmithKline

Read the declaration here.

More articles on infection control:

12 clinical research findings to know this week
Less than 20% of nurses comply with standard precautions for infection prevention
How clean is clean-shaven? Study finds beardless healthcare workers carry more bacteria on their faces

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

The capacity problem hospitals can't build their way out of

Recommended Whitepaper

Advertisement

Next Up in Clinical Leadership & Infection Control

  • AI is about to break healthcare's scarcity model — if we let it

    How many of you have felt like a flea in a jar? If you put fleas in a jar, they…

    Peter Pronovost, MD, PhD, chief quality & clinical transformation officer, University Hospitals; Meenesh Bhimani, MD, chief medical officer, Hippocratic AI; and David Sylvan, chief strategy, innovation & marketing officer, University Hospitals
Advertisement

Comments are closed.